Sinovac Biotech Ltd.
SVA · NASDAQ
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,072 | $1,270 | $1,643 | $4,278 |
| Short-Term Investments | $9,502 | $9,953 | $9,426 | $7,035 |
| Receivables | $405 | $451 | $500 | $609 |
| Inventory | $154 | $140 | $183 | $181 |
| Other Curr. Assets | $3 | $5 | $4 | $8 |
| Total Curr. Assets | $11,148 | $11,831 | $11,769 | $12,126 |
| Property Plant & Equip (Net) | $954 | $1,032 | $1,123 | $1,173 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $71 | $74 | $74 | $80 |
| Long-Term Investments | $681 | $684 | $658 | $661 |
| Tax Assets | $33 | $30 | $99 | $71 |
| Other NC Assets | $9 | $7 | $2 | $3 |
| Total NC Assets | $1,749 | $1,827 | $1,956 | $1,988 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $12,897 | $13,658 | $13,725 | $14,115 |
| Liabilities | – | – | – | – |
| Payables | $642 | $17 | $820 | $20 |
| Short-Term Debt | $179 | $76 | $205 | $5 |
| Tax Payable | $29 | $41 | $0 | $257 |
| Deferred Revenue | $7 | $22 | $19 | $33 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $978 | $1,148 | $1,190 | $1,092 |
| LT Debt | $130 | $178 | $11 | $12 |
| Deferred Rev, NC | $6 | $0 | $7 | $4 |
| Deferred Tax Liab, NC | $262 | $264 | $239 | $242 |
| Other NC Liab. | $0 | $0 | $1 | $0 |
| Total NC Liab. | $411 | $481 | $298 | $310 |
| Other Liabilities | $0 | $6 | $0 | $0 |
| Cap. Leases | $15 | $45 | $47 | $59 |
| Total Liabilities | $1,390 | $1,635 | $1,488 | $1,402 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $7,108 | $7,119 | $7,240 | $7,226 |
| AOCI | $1,000 | $1,050 | $884 | $1,155 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $8,649 | $8,709 | $8,665 | $8,921 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $2,858 | $3,313 | $3,572 | $3,791 |
| Total Liab. & Tot. Equity | $12,897 | $13,658 | $13,725 | $14,115 |
| Net Debt | -$763 | -$1,016 | -$1,427 | -$4,262 |